Alveolar Bone Atrophy Clinical Trial
Official title:
Clinical Trial of Safety and Efficacy of the Medical Item Collagen Plates With Hydroxyapol Inducing Angiogenesis, "Nukleostim", for Bone Tissue Regeneration
The purpose of this study is to evaluate safety and efficacy of gene-activated matrix ("Nucleostim") for regeneration of bone tissue in maxillofacial area. Patients with congenital and acquired maxillofacial defects (sockets of extracted teeth, bone defects after injuries, surgeries, excision of benign neoplasms and pseudotumors, etc.) or alveolar bone atrophy will be included into the study.
All patients enrolled into the study will receive standard surgery procedures indicated in accordance with medical care standards for the certain disease. Maxillofacial bone defects (formed after injuries, surgeries, excision of benign neoplasms and pseudotumors, teeth extraction, etc.) or areas of alveolar bone atrophy will be the filled by gene-activated matrix "Nucleostim". Safety and efficacy of implanted osteoplastic material will be assessed by physical examination, comprehensive laboratory tests, X-ray examination within 60 days after operation. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT02209311 -
Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Synthetic Tricalcium Phosphate and Autologous MMSCs
|
Phase 1/Phase 2 | |
Recruiting |
NCT04297813 -
Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting
|
Phase 3 | |
Completed |
NCT03357068 -
Effect of Citric Acid Demineralization on Autogenous Bone Blocks Consolidation in Humans
|
N/A | |
Completed |
NCT01268982 -
Effect of Socket Preservation Procedure on Dimensional Changes of the Ridge, and Its Efficacy.
|
Phase 2 | |
Completed |
NCT00868777 -
The Influence of Dimensional Anatomic Variables on the Outcomes of Maxillary Sinus Grafting Procedures
|
Phase 4 | |
Completed |
NCT04506827 -
RCT With 3 Different Biomaterials for Maxillary Sinus Lift
|
Phase 4 | |
Not yet recruiting |
NCT04998058 -
Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting
|
Phase 1/Phase 2 |